A nurse is assessing a patient with fibrocystic breast changes.
Which clinical findings are consistent with this condition? Select all that apply.

Choice A rationale: A single, hard, non-mobile palpable lump is more characteristic of a potential malignancy or a fibroadenoma. Fibrocystic changes typically present as diffuse, bilateral areas of thickening rather than one isolated, distinct nodule.

Choice B rationale: Hormonal fluctuations, specifically variations in estrogen and progesterone during the menstrual cycle, are the primary cause of fibrocystic changes. These hormones cause the breast tissue to retain fluid and form cysts or fibrous areas.

Choice C rationale: Fibrocystic breast disease is characterized by the presence of multiple palpable masses, lumps, or nodules. These are often described as "lumpy" or "rope-like" and are frequently found in the upper, outer quadrants of both breasts.

Choice D rationale: Genetic mutations like BRCA1 and BRCA2 are associated with a significantly increased risk for hereditary breast and ovarian cancers. They are not the causative factor for the benign glandular and stromal changes seen in fibrocystic condition.

Choice E rationale: A history of breast trauma or surgery is more likely to result in fat necrosis or surgical scarring (hematoma/seroma). While these can cause lumps, they are distinct clinical entities from the cyclical, hormone-driven nature of fibrocystic changes.

Choice A rationale:

Prioritizing lymph node assessment during the examination is crucial when evaluating a client with suspected breast pathology.

Enlarged, firm, or fixed lymph nodes in the axillary region may indicate the spread of breast cancer to the lymph nodes, which is an important factor in staging and treatment planning.

Assessing lymph nodes helps determine the extent of the disease.

Choice B rationale:

Measurement of breast size is not the primary assessment priority when evaluating a client with suspected breast pathology.

While changes in breast size can occur in various breast conditions, including breast cancer, other factors, such as the presence of masses, nipple changes, and lymph node status, are more critical indicators of pathology.

Choice C rationale:

Assessment of menstrual history may be relevant in certain cases, especially when considering hormonal factors that could influence breast conditions.

However, in the context of a client with suspected breast pathology, assessing lymph nodes and breast abnormalities takes precedence over menstrual history.

Choice D rationale:

Evaluation of emotional support needs is essential in providing comprehensive care to clients with breast pathology, but it should not be the top priority during the initial physical examination.

Assessing the physical aspects of the condition, including potential signs of malignancy, should come first to guide appropriate diagnostic and treatment interventions.

Emotional support assessment can follow as part of holistic care.